You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-angiogenics

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Collateral Damage From COVID-19 Pandemic Observed in Patients

Completed
  • Age Related Macular Degeneration
  • +2 more
  • Questionnaire
  • Data collection up to 1 year
  • Ecully, France
  • +3 more
Mar 2, 2022

Age-related Macular Degeneration Trial in Paris (OCT B-scans, OCT angiography)

Completed
  • Age-related Macular Degeneration
  • OCT B-scans
  • OCT angiography
  • Paris, France
    Fondation Ophtalmologique A. de Rotchschild
May 21, 2021

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Health Care
Jul 24, 2021

Quantifying Systemic Immunosuppression to Personalize Cancer

Recruiting
  • Melanoma
  • +6 more
  • MDSC quantification
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022

Osteonecrosis of the Jaw (ONJ) Case Registry

Completed
  • Osteonecrosis of the Jaw
    • Beverly Hills, California
    • +63 more
    Dec 18, 2020

    OCTA Versus Structural OCT(Optical Coherence Tomography) in

    Completed
    • Macular Degeneration Exudative Eye Left
    • Macular Degeneration Exudative Eye Right
    • Follow-up
    • Créteil, France
    • +2 more
    Jul 8, 2020

    Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

    Recruiting
    • Autoimmune Encephalitis
    • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
    • Clinical score of Granillo and al.
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 12, 2023

    Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

    Completed
    • Critical Illness
    • +2 more
    • blood sampling
    • Arnhem, Netherlands
      Monique de Maat
    Jun 28, 2023

    Technology Trial in Hong Kong (The anti-wandering system)

    Not yet recruiting
    • Technology
    • The anti-wandering system
    • Hong Kong, Hong Kong
      Haven of Hope Residential Service for the Disabled
    Mar 28, 2023

    NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel

    Recruiting
    • Non-small Cell Lung Cancer
    • TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
    • TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
    • Beijing, Beijing, China
    • +2 more
    Jun 19, 2023

    Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

    Recruiting
    • Seasonal Allergic Rhinitis
    • LP-003 dose 1
    • +2 more
    • Beijing, Beijing, China
    • +16 more
    Sep 18, 2023

    Celiac Disease Trial in Spain

    Recruiting
    • Celiac Disease
      • Terrassa, Barcelona, Spain
      • +5 more
      Aug 10, 2023

      Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)

      Not yet recruiting
      • Thyroid Diseases
      • +2 more
      • curcumin
      • Anti-inflammatory diet
      • Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of
        Golbon Sohrab
      Jul 27, 2023

      Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)

      Recruiting
      • Post-endodontic Pain
      • Cryotherapy
      • +2 more
      • Cairo, Egypt
        Ain Shams University
      Oct 13, 2023

      T- and B-Cell Subpopulations in Membranous Nephropathy

      Recruiting
      • Membranous Nephropathy
      • +2 more
        • Istanbul, Turkey
          Istanbul University
        May 31, 2023

        Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

        Not yet recruiting
        • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
        • +2 more
        • Biopsy
        • +6 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Sep 28, 2023

        Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

        Not yet recruiting
        • Refractory Cancer
        • +3 more
        • IMA402 (Phase Ia)
        • +2 more
        • Heidelberg, Baden-Wuerttemberg, Germany
        • +12 more
        Jul 14, 2023

        HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

        Recruiting
        • HER2-positive Gastric Cancer
        • Immunotherapy
        • Disitamab Vedotin combined with fruquintinib and Tislelizumab
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Aug 8, 2023

        Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

        Not yet recruiting
        • Locally Advanced Rectal Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Aug 5, 2023

        Wrinkle, Spot Pigmented, Lines Skin Trial in Clearwater (Nutraceutical Topical)

        Recruiting
        • Wrinkle
        • +2 more
        • Nutraceutical Topical
        • Clearwater, Florida
          Laser Scalp and Hair Center
        Feb 9, 2023

        Focal Laser Single Intravitreal Ranibizumab Retinal Artery

        Completed
        • Retinal Artery Macroaneurysm
        • Dual focal laser and intravitreal Ranibizumab injection
        • Cairo, Egypt
          Kasr alainy faculty of medicine
        Jan 29, 2023

        Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")

        Not yet recruiting
        • Ulcerative Colitis
        • "Mesalamine" and "alpha-lipoic acid"
        • "Mesalamine" and "Placebo"
        • (no location specified)
        Oct 5, 2023

        Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

        Recruiting
        • Macular Edema Due to Type 2 Diabetes Mellitus
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital, School of Medicine, Zhejiang Univers
        Feb 26, 2023

        Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

        Not yet recruiting
        • Muscle-Invasive Bladder Carcinoma
        • +2 more
        • Guangzhou, Guangdong, China
          Cancer Center, Sun Yat-sen University
        Aug 3, 2023